SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739104-20-000013
Filing Date
2020-07-30
Accepted
2020-07-30 18:45:49
Documents
81
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elan-20200630.htm   iXBRL 10-Q 2009987
2 EX-31.1 ex311elanco-20200630xc.htm EX-31.1 12508
3 EX-31.2 ex312elanco-20200630xc.htm EX-31.2 12511
4 EX-32 ex32elanco-20200630xse.htm EX-32 11535
  Complete submission text file 0001739104-20-000013.txt   8723520

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20200630.xsd EX-101.SCH 48883
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20200630_cal.xml EX-101.CAL 88372
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20200630_def.xml EX-101.DEF 332957
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20200630_lab.xml EX-101.LAB 629776
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20200630_pre.xml EX-101.PRE 453415
10 EXTRACTED XBRL INSTANCE DOCUMENT elan-20200630_htm.xml XML 1601374
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38661 | Film No.: 201061431
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences